Positive results for potential first chikungunya vaccine | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
June 18, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JUNE 18, 2025
Positive results for potential first chikungunya vaccine

World+Biz

BSS/AFP
13 June, 2023, 09:15 am
Last modified: 13 June, 2023, 09:20 am

Related News

  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Chikungunya cases rise amid ongoing dengue crisis

Positive results for potential first chikungunya vaccine

BSS/AFP
13 June, 2023, 09:15 am
Last modified: 13 June, 2023, 09:20 am
FILE PHOTO: A Ugandan health worker prepares to administer the ebola vaccine to a man in Kirembo village, near the border with the Democratic Republic of Congo in Kasese district, Uganda, June 16, 2019. REUTERS/James Akena/
FILE PHOTO: A Ugandan health worker prepares to administer the ebola vaccine to a man in Kirembo village, near the border with the Democratic Republic of Congo in Kasese district, Uganda, June 16, 2019. REUTERS/James Akena/

French-Austrian drugmaker Valneva's vaccine candidate against chikungunya, a mosquito-borne virus which causes occasional outbreaks across the world, showed promising results in a large new trial, a study said on Tuesday.

While the results were hailed as good news in the fight against chikungunya, the trial was carried out on people in the United States where the virus is extremely rare, with experts saying more research was needed.

There are currently no vaccines or treatments available for the virus, which causes fever and sometimes debilitating joint pain, though it is rarely fatal.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Valneva says that its vaccine candidate, called VLA1553, is the first to be reviewed by health authorities after applying for approval in the US and Canada.

The new randomised, placebo-controlled phase three trial aimed to find out how often the live-attenuated vaccine, which uses a weakened form of the virus, produced an immune response.

Out of a subgroup of 266 people who received the vaccine, 263 -- 99 percent -- developed antibodies that could neutralise the chikungunya virus, according to the study published in The Lancet journal.

In a broader trial of 4,100 healthy adults, the single-shot vaccine was deemed "generally safe," with side effects similar to other vaccines.

Only two people developed serious side effects linked to the vaccine, the study said, and both fully recovered.

Martina Schneider, Valneva's clinical strategy manager and the lead author of the study, called the results "promising".

"This could be the first chikungunya vaccine available for people living in endemic regions, as well as for travellers to endemic areas or areas at risk for an upcoming outbreak," she said in a statement.

Outbreak trials 'crucial'

Public health experts have expressed concerns that chikungunya could be a potential future pandemic threat as climate change pushes the mosquitoes that spread it into new regions.

Kathryn Stephenson, an infectious disease specialist at the Beth Israel Deaconess Medical Center in the US, said the new study was "good news for chikungunya virus pandemic preparedness".

However the vaccine might be less effective in areas with a built-up immunity to chikungunya, which can happen with such live-attenuated shots, she added.

Since chikungunya was first identified in Tanzania in 1952, it has been recorded in more than 110 countries, according to the World Health Organization.

Occasional but severe outbreaks take place in Africa, Asia and the Americas.

Valneva has said the US Food and Drug Administration could make a decision on approving the vaccine at the end of August.

The company is also trialling the vaccine among adolescents in areas of Brazil where the virus is endemic.

Stephenson said the Brazilian trial and further research conducted during actual chikungunya outbreaks were "crucial" to establishing the vaccine's effectiveness.

A chikungunya vaccine candidate developed by Denmark's Bavarian Nordic is also undergoing phase three trials.

Top News

chikungunya / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Missiles launched from Iran are intercepted as seen from Ashkelon, Israel, June 18, 2025. REUTERS/Amir Cohen
    Israel-Iran attacks continue as Trump warns Tehran's that US patience wearing thin
  • Israel strikes Iran's capital Tehran on Sunday night. File Photo: Collected
    Israeli strike damages home of Bangladeshi diplomat in Tehran
  • Iran's Supreme Leader Ayatollah Ali Khamenei speaks during a meeting with defence industry experts in Tehran, Iran, February 12, 2025. Photo: Office of the Iranian Supreme Leader/WANA (West Asia News Agency)/Handout via REUTERS/File Photo
    Iran's Khamenei vows 'no mercy' for Israel leaders

MOST VIEWED

  • Infograph: TBS
    Govt to ease loan rules to help foreign firms expand in Bangladesh
  • A view of Iranian missiles across the sky as seen by Biman pilot Enam Talukder. Photo: Enam Talukder
    Biman pilot witnessed Iran's missiles flying towards Israel
  • Global map showing nuclear weapon inventories by country as of January 2025, including deployed, stored, and retired warheads. Source: SIPRI
    How Israel's secret nuclear arsenal comes under spotlight amid attacks on Iran
  • Infograph:TBS
    Overseas employment back in flow as Saudi recruitment picks up in May
  • Google Pay. Photo: Collected
    Google Pay coming to Bangladesh next week
  • European Council President Antonio Costa, Japan's Prime Minister Shigeru Ishiba, Italian Prime Minister Giorgia Meloni, French President Emmanuel Macron, Canada's Prime Minister Mark Carney, US President Donald Trump, British Prime Minister Keir Starmer, German Chancellor Friedrich Merz and European Commission President Ursula von der Leyen pose for a family photo during the G7 Summit, in Kananaskis, Alberta, Canada, June 16, 2025. Photo: REUTERS/Suzanne Plunkett/Pool
    G7 expresses support for Israel, calls Iran source of instability

Related News

  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Chikungunya cases rise amid ongoing dengue crisis

Features

The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

20h | Panorama
The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

2d | Wheels
Renowned authors Imdadul Haque Milon, Mohit Kamal, and poet–children’s writer Rashed Rouf seen at Current Book Centre, alongside the store's proprietor, Shahin. Photo: Collected

From ‘Screen and Culture’ to ‘Current Book House’: Chattogram’s oldest surviving bookstore

2d | Panorama
Photos: Collected

Kurtis that make a great office wear

4d | Mode

More Videos from TBS

Trump brand expands again; this time into mobile phones

Trump brand expands again; this time into mobile phones

14m | Others
US to transfer 30 fighter jets to Europe

US to transfer 30 fighter jets to Europe

49m | TBS World
Will Trump take the ladder and hang Netanyahu from a tree?

Will Trump take the ladder and hang Netanyahu from a tree?

2h | Others
Did Iran take revenge for the killing of nuclear scientists?

Did Iran take revenge for the killing of nuclear scientists?

3h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net